Are anti-oxidant and anti-inflammatory treatments effective in different subgroups of COPD? A hypothesis (Q77929328)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

review article

1 reference

title

Are anti-oxidant and anti-inflammatory treatments effective in different subgroups of COPD? A hypothesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

9 December 2019

main subject

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

C P van Schayck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

P N Dekhuijzen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

W J Gorgels

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

P M van Grunsven

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J Molema

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C L van Herwaarden

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

1259-1264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9926137%20AND%20SRC:MED&resulttype=core&format=json

Reassessment of inflammation of airways in chronic bronchitis

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Oxidative Stress in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Bacterial infection in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Tissue destruction by neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Relation between small airways disease and parenchymal destruction in surgical lung specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Histological features of the airways in asthma and COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Systemic oxidative stress in asthma, COPD, and smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Comparative morphology of the airways in asthma and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Inhaled corticosteroids in COPD: awaiting controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Do patients with COPD benefit from treatment with inhaled corticosteroids?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Aerosol beclomethasone in patients with steroid-responsive chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Time course of response to oral and inhaled corticosteroids in non-asthmatic chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflo

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Failure of Inhaled Corticosteroids to Modify Bronchoconstrictor or Bronchodilator Responsiveness in Middle-Aged Smokers with Mild Airflow Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Effects of long-term treatment with corticosteroids in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Inhaled budesonide therapy for patients with stable COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Glutathione metabolism and utilization of external thiols by cigarette smoke-challenged, isolated rat and rabbit lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Inhibition by oral N-acetylcysteine of cigarette smoke-induced "bronchitis" in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Pulmonary strategies of antioxidant defense

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

Stimuli-induced superoxide radical generation in vitro by human alveolar macrophages from smokers: modulation by N-acetylcysteine treatment in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021

The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990225-6

7 January 2021